Nonsteroidal Treatment for Inflammatory Skin Diseases
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
I-Derm develops a nonsteroidal topical treatment for inflammatory skin diseases based on a novel mechanism of action. This mechanism directly targets cutaneous elements rather than the immune system and is therefore uniquely functional only on the skin. This novel treatment is targeted as a nonsteroidal topical treatment for psoriasis.
The molecule, CPT-11, up-regulates SAMD9, which in turn down-regulates EGR1, a critical regulator of inflammatory responses of the skin, in a dose-dependent manner.